Tenet Healthcare Corporation reports developments across a diversified healthcare services business that combines ambulatory surgery, hospital operations and healthcare-services outsourcing. Its care delivery network includes United Surgical Partners International, which operates ambulatory surgery centers and surgical hospitals, along with acute care and specialty hospitals, outpatient facilities, employed physician networks and a global business center in Manila.
Recurring news themes for THC include quarterly earnings, financial outlooks, same-facility revenue trends, Ambulatory and Hospital segment performance, payer-mix and expense-management commentary, and capital or ownership actions involving Conifer Health Solutions. Company updates also cover Conifer's revenue cycle management and value-based care services for hospitals, health systems, physician practices, employers and other clients, as well as Tenet's presentations at healthcare investor conferences.
Tenet Healthcare (THC) will release its third quarter 2026 results before the market opens on October 29, 2026. A conference call will follow at 9:00 a.m. CT (10:00 a.m. Eastern Time). A live webcast and audio archive will be accessible through the investor relations section of Tenet’s website.
Tenet Healthcare (THC) priced a private offering of $2.0 billion senior notes due September 15, 2034, bearing interest at 6.250% per annum.
The offering size was increased from $1.5 billion, with closing expected on September 22, 2026, subject to customary conditions. Tenet plans to use net proceeds, together with cash on hand, to redeem all $1.5 billion of its 5.125% senior secured first lien notes due November 2027 and to partially redeem $0.5 billion of its 6.125% senior notes due October 2028. The new notes are unsecured, rank pari passu with existing and future senior unsecured debt, are senior to unsecured subordinated obligations, and are effectively and structurally subordinated to certain other obligations.
The notes will be offered only to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S, and will not be registered under the Securities Act.
Tenet Healthcare (THC) plans a private placement of $1.5 billion in new senior notes due 2034 to refinance an equal amount of existing notes.
Net proceeds, along with cash on hand, are intended to fund the redemption of all outstanding 5.125% senior secured first lien notes due November 2027. The new notes will be unsecured obligations, pari passu with Tenet’s other senior unsecured debt and effectively subordinated to its senior secured obligations. The offering will be limited to qualified institutional buyers under Rule 144A and certain non‑U.S. persons under Regulation S.
Tenet Healthcare (THC) will present at the Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, starting at 12:45 p.m. Eastern Time.
A live webcast and 30-day replay will be available via the investor relations section of Tenet’s website at www.tenethealth.com/investors.
Tenet Healthcare (NYSE: THC) reported second quarter 2026 net operating revenues of $5.63 billion, up 6.8% year-over-year, and net income available to common shareholders of $826 million, or $9.84 per diluted share, versus $288 million, or $3.14, in 2025. Adjusted diluted EPS rose 52.2% to $6.12 and consolidated Adjusted EBITDA increased 16.3% to $1.304 billion with a 23.2% margin, exceeding prior guidance assumptions.
Ambulatory segment Adjusted EBITDA was $542 million, up 8.8%, with a 39.0% margin, while Hospital segment Adjusted EBITDA rose to $762 million, a 22.3% increase and 18.0% margin, aided by higher acuity and Medicaid supplemental revenues. The Board approved a $2.0 billion increase to the share repurchase program, leaving $2.13 billion authorized. Tenet raised its 2026 Outlook, now guiding to Adjusted EBITDA of $4.83–$5.03 billion and Adjusted free cash flow of $2.725–$3.025 billion.
Tenet Healthcare (NYSE:THC) will release its second quarter 2026 results before the market opens on Friday, July 24, 2026, followed by a conference call at 10:30 a.m. CT (11:30 a.m. ET). A live webcast and audio archive will be available via its investor relations website.
Tenet Healthcare (NYSE: THC) will present at the BofA Securities Health Care Conference on Wednesday, May 13, 2026 at 6:00 p.m. ET. A live webcast and audio archive will be available via Tenet's investor relations website, with a replay accessible for 30 days.
Tenet Healthcare (NYSE: THC) reported first quarter 2026 results: net income $702 million ($8.01 diluted), Adjusted diluted EPS $4.82 (up 10.6% YoY), and Consolidated Adjusted EBITDA $1.162 billion with a 21.6% margin. Net operating revenues were $5.368 billion. Free cash flow and adjusted free cash flow improved; FY 2026 Adjusted EBITDA outlook is $4.485–$4.785 billion.
Results reflect contributions from the CommonSpirit agreement (one-time revenue recognition), stronger ambulatory same-facility revenues, offset by unfavorable payer mix and lower exchange admissions in hospitals.
Tenet Healthcare (NYSE: THC) will report first quarter 2026 results before market open on Thursday, April 30, 2026, followed by a conference call at 9:00 a.m. CT (10:00 a.m. ET).
A live webcast and an audio archive will be available via Tenet's investor relations website at www.tenethealth.com/investors.
Tenet Healthcare (NYSE: THC) will present at the Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 9:30 a.m. ET.
A live webcast and audio archive will be available via the company's investor relations site, with a replay accessible for 30 days.